GSK continues to monitor the rapidly evolving COVID-19 situation alongside public health authorities, including Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), and medical experts. None of these agencies currently recommend that individuals should stop taking ibuprofen/Advil.
ADVIL AND COVID-19
As a leader in the OTC pain category, GSK Consumer Healthcare is not aware of any scientific evidence that directly links worse
outcomes in patients suffering from COVID-19 infection with the use of ibuprofen or other anti-inflammatories. Learn more here.